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In a fully functional immune system, the size 
and diversity of the CD4+ T cell pool is main-
tained at a constant level by homeostatic mech-
anisms  (Freitas  and  Rocha,  1993;  Bell  and 
Sparshott, 1997; Min et al., 2005). Immune cell 
insufficiency and dysregulation of CD4+ T cell 
homeostasis is associated with a variety of pri-
mary disease conditions. These include autoim-
munity (Jonsson et al., 2002), chronic infection 
(McMichael  and  Rowland-Jones,  2001),  and 
cancer (Miller et al., 1997), conditions that can 
lead to cachexia, the dramatic wasting syndrome 
seen in many chronic diseases (Lainscak et al., 
2008). Previously, we showed that cachexia and 
cachexia-associated lymphopenia was inhibited 
by the infusion of CD4+ CD44v.low cells into 
mice with cancer (Wang et al., 2008).
CD4+ CD44v.low cells are operationally de-
fined as those cells with the lowest CD44 ex-
pression. The cell surface expression of CD44 is 
used to phenotypically distinguish naive from 
memory CD4+ T cells. Thus, naive cells express 
a low level of CD44 (CD44low), whereas mem-
ory cells express a high level (CD44high; Budd   
et al., 1987; Swain, 1994). CD4+ CD44v.low cells 
constitute the 2–5% of the total naive CD4+ 
CD44low  cell  population  that  expresses  the   
lowest density of CD44. They also express a high 
density of both CD45RB and CD62L (Zhao   
et al., 2008), which also define them as being 
naive (Bottomly et al., 1989; Lee et al., 1990; 
Swain, 1994). The naive CD4+ CD44low cells that 
are not CD4+ CD44v.low cells have been termed 
CD44 intermediate (CD44int; Wang et al., 2008). 
Thus, naive CD4+ CD44low cells consists of two 
populations, CD4+ CD44v.low cells and CD4+ 
CD44int cells. CD4+ CD44v.low cells were first 
identified by the observation that CD4+ cells 
expressing a very low density of CD44 are   
absent from the spleens and lymph nodes of   
cachexic mice (Zhao et al., 2008). In contrast, 
neither  CD4+  CD44int  nor  CD4+  CD44high 
cells are absent from these mice (Zhao et al., 
2008). Moreover, unlike CD4+ CD44v.low cells, 
CD4+ CD44int and CD4+ CD44high cells do 
not  inhibit  cachexia  and  cachexia-associated 
lymphopenia, indicating a novel function for 
CD4+ CD44v.low cells (Wang et al., 2008).
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Mechanisms that control the size of the T cell pool, the ratio between naive cells and 
memory cells, the number and frequency of regulatory T cells, and T cell receptor (TCR) 
diversity are necessary to maintain immune integrity and avoid disease. We have previously 
shown that a subset of naive CD4+ T cells, defined by the expression on their surface of  
a very low density of CD44 (CD44v.low cells), can inhibit wasting and wasting-associated 
lymphopenia in mice with cancer. In this study, we further investigate the properties of 
CD44v.low cells and show that they are significantly more efficient than the remaining naive 
(CD44low or CD44int) and memory CD4+ cell subsets in reconstituting the overall size of the 
CD4+ T cell pool, creating a T cell pool with a diverse TCR repertoire, generating regulatory 
T cells that express forkhead box P3 (FoxP3), and promoting homeostatic equilibrium 
between naive, memory, and Foxp3+ regulatory T cell numbers. T cell population reconstitu-
tion by CD44v.low cells is thymus independent. Compared with CD44int cells, a higher per-
centage of CD44v.low cells express B cell leukemia/lymphoma 2, interleukin-7 receptor, and 
CD5. The data support a key role for CD4+ CD44v.low cells as peripheral precursors that 
maintain the integrity of the CD4+ T cell pool.
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and 13 wk were very similar. Therefore, mice were analyzed 
at 3 wk after cell transfer in all subsequent experiments.
In these experiments, it was possible that CD4+ CD44high 
cells present within the CD44v.low-depleted CD4+ cells may 
have suppressed the capacity of CD4+ CD44int cells to expand 
and accumulate. To exclude this possibility we compared the 
ability of CD4+ CD44v.low, or CD4+ CD44int, or CD4+ CD44low 
(containing CD4+ CD44v.low and CD4+ CD44int) cells to 
reconstitute SCID mouse recipients. As shown in Fig. 1 B, the 
size  of  the  CD4+ T  cell  population  derived  from  CD4+ 
CD44v.low  cells  was  significantly  greater  than  that  derived 
from  either  CD4+  CD44low  cells  or  CD4+  CD44int  cells. 
These  data  are  consistent  with  the  hypothesis  that  CD4+ 
CD44v.low cells are superior to CD4+ CD44int cells in their 
capacity to expand in lymphopenic hosts, and that the two are 
functionally distinct populations within the CD4+ CD44low 
naive cells.
CD4+ CD44v.low cells generate naive and memory phenotype 
cells at a ratio that suggests homeostatic equilibrium
Under normal circumstances, the ratio of naive and memory 
T cells in the periphery is highly regulated. To determine if 
CD4+  CD44v.low  cells  retain  a  normal  ratio  of  naive  and 
memory cells, CB17.SCID mice were infused with CD4+ 
CD44v.low cells, CD4+ CD44int cells, CD4+ CD44high cells,   
or with no cells, and the number and ratio of CD4+ T cell 
subsets was determined 3 wk later. CD4+ CD44int cells and 
CD44high cells were shown to be equivalent in their ability to 
expand and accumulate CD4+ T cells, but both were signifi-
cantly less efficient than CD4+ CD44v.low cells (Fig. 2 A).   
In addition, CD4+ CD44v.low cells are significantly more ef-
fective in producing populations of CD4+ CD44int (Fig. 2 B) 
and CD4+ CD44high (Fig. 2 C) cells than those that were in-
fused CD4+ CD44int and CD4+ CD44high cells themselves. 
Moreover, whereas splenocytes from mice infused with CD4+ 
CD44v.low  cells  contained  substantial  numbers  of  CD4+ 
CD44v.low cells, CD4+ CD44int cells were very inefficient at 
producing these cells (Fig. 2 D).
The ratio of cells with a naive phenotype (CD4+ CD44v.low 
and CD44int cells) and a memory phenotype (CD44high cells) 
in mice reconstituted with CD4+ CD44v.low cells was very 
similar to that in untreated BALB/c mice (Fig. 2 E). Thus, the 
CD4+ CD44v.low cells more efficiently expand a cell popula-
tion with a naive phenotype than do CD4+ CD44int cells. In 
contrast, the CD4+ CD44int cells and CD4+ CD44high cells are 
more efficient in expanding the memory cell pool than the 
CD4+ CD44v.low cell population (Fig. 2 E). Thus, the ex-
panded cell population derived from CD4+ CD44v.low cells 
retained a ratio of naive/memory cells that was similar to that 
in untreated wild-type animals.
CD4+ CD44v.low cells generate Foxp3+ regulatory cells more 
efficiently than do CD4+ CD44int cells
A functionally balanced immune system depends on the pres-
ence of regulatory cells, including those that express Foxp3 
(regulatory T cells [Tregs]). Foxp3-expressing cells are either 
In this study, we further describe the properties of this 
novel CD4+ T cell subset and show that it has a unique abil-
ity to maintain the integrity of the CD4+ T cell population 
by expanding and differentiating into naive, memory, and 
forkhead box P3 (Foxp3)+ regulatory CD4+ T cell subsets 
having a diverse TCR repertoire. Collectively, the data sup-
port a key role for CD4+ CD44v.low cell function as part of 
the homeostatic mechanism to maintain the size and diversity 
of the CD4+ T cell pool. These findings indicate that en-
hancing CD4+ CD44v.low cell numbers or their function may 
provide a therapeutic approach for disease- and drug-induced 
lymphopenia and lymphopenia-associated disease.
RESULTS
CD4+ CD44v.low cells are significantly more effective  
than other naive CD4+ cells in their ability to expand  
and accumulate in lymphopenic hosts
To test the capacity of CD4+ CD44+ cells to repopulate pe-
ripheral T cells in lymphopenic hosts, groups of CB17. Severe 
combined  immunodeficiency  (SCID)  mice  were  injected 
with CD4+ CD44v.low cells, with CD44v.low-depleted CD4+ 
cells (i.e., that contained CD44int and CD44high cells), or with 
no cells. The number of CD4+ T cells in the spleens of recipi-
ent mice at 9 and 13 wk after cell infusion was then deter-
mined by FACS analysis. Mice that were injected with CD4+ 
CD44v.low cells contained significantly more CD4+ T cells 
than did mice that received CD44v.low-depleted CD4+ cells 
(Fig. 1 A). This was also observed in lymph nodes (unpub-
lished data). Notably, the levels of CD4+ reconstitution at 3, 9, 
Figure 1.  CD4+ CD44v.low cells are significantly more effective in 
their ability to expand and accumulate in lymphopenic hosts than 
other naive CD4+ cells. (A) CB17.SCID mice were injected with 2.5 × 105 
purified CD4+ CD44v.low cells (n = 4), with an equal number of purified 
CD4+ cells depleted of CD44v.low cells (CD44v.low dep; n = 4), or with no 
cells (n = 4). Mice were sacrificed at 9 (n = 2 per group) or 13 (n = 2 per 
group) wk after cell transfer, and the number of CD4+ T cells in the 
spleens was determined by FACS. Data were pooled for each group at the 
two time points. (B) CB17.SCID mice were injected with 2.5 × 105 purified 
CD4+ CD44v.low cells (n = 6), with CD4+ CD44int cells (n = 6), with CD4+ 
CD44low cells (n = 5), or with no cells (n = 2). Mice were sacrificed 3 wk 
after cell transfer, and the number of CD4+ T cells in the spleens was de-
termined by FACS. Data are shown as mean ± SEM and are representative 
of two independent experiments. One-way ANOVA shows a significance 
of P = 0.005 for A and P = 0.001 for B. Significance between groups using 
Bonferroni’s multiple comparison test is indicated on the figures.  
*, P = 0.01–0.05; **, P = 0.001–0.01.JEM VOL. 207, December 20, 2010 
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CD44int subset were then transferred into SCID mice, and the 
expression of Foxp3 in spleen CD4+ T cells was determined 
3 wk later.
In animals infused with CD4+ CD44v.low cells, between   
10 and 20% of CD4+ T cells expressed Foxp3 (Fig. 3 A).   
Although mice that received Foxp3-depleted CD4+ CD44int 
cells did generate CD4+ Foxp3+ cells, their reconstitution was 
much  more  inefficient  with  respect  to  both  percentage   
(Fig. 3 A) and total number (Fig. 3 B) of Foxp3+ cells when 
compared with mice that received CD4+ CD44v.low cells.
Reconstitution of CD4+ naive and regulatory cells  
by CD44v.low cells does not require thymopoiesis
The mechanism of naive cell reconstitution in lymphopenic 
hosts has been studied extensively, and the conclusion thus far 
is  that  naive  cells  can  only  be  generated  by  thymopoiesis   
(Ge et al., 2002). Our data challenge this paradigm by sug-
gesting that naive cells can be generated in the periphery 
from CD4+ CD44v.low precursor cells (Fig. 2 B). The genera-
tion of Foxp3+ cells from naive cell inoculation into lympho-
penic hosts has also not been previously described, and our 
data suggest that naive CD4+ CD44int cells are not efficient in 
this respect (Fig. 3). To exclude the possibility that the CD4+ 
CD44v.low cells, or a subset of cells within the CD4+ CD44v.low 
cell population migrate to the thymus and develop into cells 
that then seed the peripheral immune system, we tested the 
ability of CD4+ CD44v.low cells to reconstitute naive, memory, 
and Foxp3+ regulatory cells in thymectomized CB17.SCID   
mice. CD4+ CD44v.low cells reconstituted total CD4 (Fig. 4 A), 
Foxp3+ (Fig. 4 B), CD44v.low (Fig. 4 C), CD44int (Fig. 4 D), 
and CD44high (Fig. 4 E) cells equally well in thymectomized 
and  euthymic  CB17.SCID  mice.  Reconstitution  of  cell   
subsets by CD44int cells is shown as a comparison to empha-
size efficient reconstitution by CD44v.low cells (Fig. 4, A–E). 
rare or absent in purified CD4+ CD44v.low cells, but are read-
ily detectable in CD4+ CD44int cells (Fig. S1 and Table S1). 
Thus, to determine the relative ability of CD4+ CD44v.low and 
CD4+ CD44int cells to reconstitute Foxp3+ Tregs, we depleted 
Foxp3-expressing cells from CD4+ CD44int population by 
cell sorting. For these experiments, the source of each puri-
fied  cell  population  was  the  Foxp3-GFP  mouse  strain,  in 
which  all  Foxp3-expressing  cells  coexpress  GFP.  Sorted 
Foxp3 cells of either the CD4+ CD44v.low or the CD4+ 
Figure 2.  CD4+ CD44v.low cells generate naive and memory  
phenotype cells at a ratio that suggests homeostatic equilibrium. 
CB17.SCID mice were injected with 2.5 × 105 purified CD4+ CD44v.low 
cells (n = 5), purified CD4+ CD44int cells (n = 4), purified CD4+ memory 
(CD44high) cells (n = 4), or no cells (n = 4). Mice were sacrificed 3 wk 
after cell transfer, and the number of total CD4+ T cells (A), CD4+ CD44int 
cells (B), CD4+ CD44high cells (C), and CD4+ CD44v.low cells (D) in the 
spleens was determined by FACS. (E) The percentage of CD4+ T cells that 
express CD44v.low (black bars), CD44int (hatched bars), or CD44high (white 
bars) phenotypes in spleens of untreated BALB/c mice (control) and in 
SCID mice reconstituted with CD4+ CD44v.low, CD4+ CD44int, or CD4+ 
CD44high cells. Data are shown as mean ± SEM, are pooled from two 
separate experiments, and are representative of three independent ex-
periments. One-way ANOVA showed significance of P < 0001, P < 0.001, 
P = 0.004, and P = 0.001 for A, B, C, and D, respectively. Significance 
between groups using Bonferroni’s multiple comparison test is indicated 
on the figures. **, P = 0.001–0.01; ***, P < 0.001.
Figure 3.  CD4+ CD44v.low cells reconstitute Foxp3+ cells more  
efficiently than CD4+ CD44int cells. CB17.SCID recipients were injected 
with 2.5 × 105 CD4+ CD44v.low cells (n = 8) or an equal number of CD4+ 
CD44int cells sorted from GFP CD4+ splenocytes (n = 10) from Foxp3-GFP 
transgenic mice, or with no cells (n = 8). 3 wk later, the percentage (A) 
and the total number (B) of CD4+ Foxp3+ cells were determined by FACS. 
The experiment was performed twice, and the data presented are pooled 
from the two independent experiments and shown as mean ± SEM. One-
way ANOVA showed significance of P < 0001 and P = 0.007 for A and B, 
respectively. Significance between groups using Bonferroni’s multiple 
comparison test is indicated on the figures. *, P = 0.01–0.05; *** P < 0.001.2886 Peripheral precursor of CD4+ T cell populations | Zhao and Davies
compared with peritoneal injection. However, consistent with 
data shown in Figs. 1–4, reconstitution of total CD4 (Fig. 5 A), 
CD44v.low (Fig. 5 B), CD44int (Fig. 5 C), CD44high (Fig. 5 D), 
and Foxp3+ (Fig. 5 E) cell subsets is significantly more effi-
cient in mice given CD4+ CD44v.low cells than in mice given 
CD4+ CD44int cells when infused via the intravenous route, 
indicating that efficient reconstitution of naive and regulatory 
cells by CD4+ CD44v.low cells is not restricted to reconstitu-
tion via the peritoneal route.
The CD4+ CD44v.low cells are functionally naive
To determine whether CD4+ CD44v.low cells have the func-
tional characteristics of naive CD4+ T cells consistent with 
their naive phenotype (Zhao et al., 2008), we tested their abil-
ity to proliferate in response to anti-CD3 mAb, and their de-
pendency on co-stimulation, compared with the naive CD4+ 
CD44int cells. CD4+ Foxp3+ cells are known to influence   
T cell proliferation, and because Foxp3+ cells are not equally 
distributed within the CD4+ cell subsets to be tested, Foxp3 
cell subsets were sorted from Foxp3-GFP mice to yield highly 
purified CD4+ CD44v.low Foxp3 cells, CD4+ CD44int Foxp3 
cells, and CD4+ CD44high Foxp3 cells. The cells were cultured 
with plate-bound anti-CD3, in the presence and absence of 
anti-CD28 mAb co-stimulation. Proliferation was measured 
daily from day 2–5 of culture. As expected, we found that 
proliferation of memory CD4+  T cells was significantly greater 
than proliferation of naive CD4+ CD44int cells to anti-CD3 
alone (Fig. 6 A). Proliferation by memory CD4+ CD44high 
and CD4+ CD44int cells was also significantly greater than 
proliferation by CD4+ CD44v.low cells under the same 
culture conditions (Fig. 6 A). However, CD4+ CD44v.low 
cells proliferated more vigorously than CD4+ CD44int 
cells in the presence of anti-CD28 (Fig. 6 B), suggesting 
that they possess greater sensitivity to co-stimulation.
We next measured IL-2 levels on days 3 and 4 of 
culture, and found significantly lower levels in the super-
natants  harvested  from  CD4+  CD44v.low  cells  com-
pared with those from CD4+ CD44int cells (Fig. 6 C). 
Because CD44int cells contain Foxp3+ cells it is likely that a 
significant proportion of the Foxp3+ cells in this group are 
Foxp3+ Tregs present in the initial cell inoculum and not 
newly converted Foxp3+ Tregs.
Previously published studies show that naive T cells can 
circulate back to the thymus in SCID and Rag-deficient re-
cipient mice (Surh et al., 1992; Kirberg et al., 2008). To deter-
mine whether CD44v.low cells have a similar capacity, euthymic 
mice were infused with either CD44v.low or CD44int cells, 
and the number of CD3+ cells was determined 3 wk later. 
CD44v.low- (Fig. 4 F) and CD44int-derived (Fig. 4 G) cells circu-
late to the thymus with similar capacity, with 0.52 ± 0.19%   
and 0.66 ± 0.12% thymus cells in mice infused with either 
CD44v.low or CD44int cells expressing CD3, respectively. More-
over, the CD3+ cells in thymi of both groups were CD4+ 
CD8 single-positive, suggesting that neither CD44v.low nor 
CD44int cells colonize the thymus with immature thymocytes 
for later export into the periphery (Fig. 4 F and Fig. 4 G).
Intravenous injection of CD44v.low cells also results  
in reconstitution of naive and regulatory CD4+ cells
The route of T cell inoculation can result in both qualitative 
and quantitative differences in immune cell function. To de-
termine whether the capacity of CD4+ CD44v.low cells to re-
constitute naive and regulatory cell subsets is restricted to 
inoculation by the peritoneal route, we directly compared re-
constitution  of  both  CD4+  CD44v.low  and  CD4+  CD44int 
cells by peritoneal and intravenous injection. Reconstitution 
by both cell subsets is more efficient when infused intravenously 
Figure 4.  Reconstitution of CD4+ naive and regulatory 
cells by CD44v.low cells does not require thymopoiesis.  
Euthymic (Eu, n = 6) and thymectomized (Thx, n = 3) CB17.SCID 
mice were reconstituted with 2.5 × 105 purified CD4+ CD44v.low 
cells. An additional group of euthymic CB17.SCID mice was 
infused with 2.5 × 105 purified CD4+ CD44int cells (n = 6). 3 wk 
later, the total number of CD4+ (A), Foxp3+ (B), CD44v.low (C), 
CD44int (D), and CD44high (E) cells in the spleens of thymecto-
mized and euthymic mice was determined by FACS. At the same 
time, the thymi were removed from all euthymic CD44v.low  
(F) and CD44int (G) recipient mice. Single-cell suspensions were 
co-stained with antibodies specific for CD3, CD4, and CD8 and 
analyzed by FACS. Dot plots are gated on CD3+ cells and are 
representative of all samples in two experiments. Data are 
shown as mean ± SEM and are representative of two experi-
ments. Significance between groups is indicated on the panels. 
*, P = 0.01–0.05; **, P = 0.001–0.01; and ***, P < 0.001.JEM VOL. 207, December 20, 2010 
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Similarly, intracellular measurements of IL-2 on day 3 of cul-
ture confirmed that fewer CD4+ CD44v.low cells produced 
IL-2 than did CD4+ CD44int cells at this time point (Fig. 6 D-F). 
The percentage of CD4+ CD44v.low cells that expressed cell 
surface CD25 (63.8% ± 0.7) on the third day of culture was 
lower than that of CD4+ CD44int cells (73.8% ± 2.4), suggest-
ing that the low levels of IL-2 in the CD4+ CD44v.low cell 
cultures reflect less efficient secretion rather than increased 
consumption of the IL-2. Collectively, these data confirm that 
the CD44v.low cells are functionally naive.
To determine whether the proliferation seen in the CD4+ 
CD44v.low cell cultures represented many rounds of division of 
a small proportion of cells, or fewer rounds of division of a 
large proportion of the cells, proliferation was also measured 
by CFSE dilution. Thus, purified CD4+ CD44v.low and CD4+ 
CD44int cells were CFSE labeled, cultured with and without 
anti-CD3 and anti-CD28 mAb, and analyzed by FACS on 
Figure 5.  i.v. injection of CD44v.low cells also results in reconstitu-
tion of naive and regulatory CD4+ cells. CB17.SCID mice were injected 
with 2.5 × 105 purified CD4+ CD44v.low cells (n = 7) or an equal number of  
purified CD4+ CD44int cells (n = 7) by the i.p. (n = 4 per group) or i.v. (n = 3  
per group) route. Mice were sacrificed 3 wk after cell transfer, and the 
number of total CD4+ (A), CD44v.low (B), CD44int (C), CD44high (D), and 
Foxp3+ (E) cells in the spleens determined by FACS. Data are shown as 
mean ± SEM, and are representative of two independent experiments. 
Significance between groups is indicated on the figures. *, P = 0.01–0.05; 
**, P = 0.001–0.01.
Figure 6.  The CD4+ CD44v.low cells are functionally naive. CD4+ 
Foxp3 CD44v.low (red) cells, CD4+ Foxp3 CD44int (blue) cells, and CD4+ 
Foxp3 CD44high (green) cells were sorted from GFP-Foxp3 splenocytes and 
incubated in triplicate at a concentration of 2 × 105 cells/ml with anti-CD3 
(1 µg/ml) in the absence (A) and presence (B–F) of 1 µg/ml anti-CD28. At 2, 
3, 4, and 5 d of culture, the cells were harvested after pulsing for the previ-
ous 16 h with [3H]thymidine, and proliferation was measured (A and B). 
Supernatant was harvested on days 2, 3, and 4, and the concentration of  
IL-2 was determined by ELISA (C). On day 3 of the culture, wells were pooled 
and the percentage of IL-2+ cells was determined by FACS (D). Dot plots 
gated on CD4+ T cells show IL-2 expression in CD4+ CD44v.low cells (E) and 
CD4+ CD44int cells (F) by intracellular staining. The lower horizontal edge of 
the box R1 is based on the isotype control staining for anti–IL-2 mAb. The 
data shown are mean ± SD and are representative of three independent 
experiments. In a separate experiment, purified CD4+ CD44v.low (G) and CD4+ 
CD44int (H) cells were labeled with CFSE, cultured in triplicate either with 
anti-CD3 or anti-CD28 mAb as before or with no stimulation, and analyzed 
by FACS 3 d later. Stimulated, red; unstimulated, black dotted line. Data 
shown are representative of three individual cultures and in two indepen-
dent experiments. Two-way ANOVA showed significance of P < 0001,  
P < 0.001, and P = 0.0008 for panels A, B, and C, respectively. Groups were 
compared using Bonferroni’s multiple comparison test; in A, CD4+ CD44int is 
significantly greater than CD4+ CD44v.low on days 3 (P < 0.001) and 4 (P = 
0.01–0.05), and CD4+ CD44high is significantly greater than CD4+ CD44int on 
days 1 (P = 0.01–0.05) 2, 3, and 4 (P < 0.001 for all 3 d). In B, CD4+ CD44v.low 
is significantly greater than CD4+ CD44int on all days tested (P < 0.001 for 
all days). In panel C, CD4+ CD44int is significantly greater than CD4+  
CD44v.low on days 3 and 4 (P = 0.001–0.01 and P < 0.001, respectively).2888 Peripheral precursor of CD4+ T cell populations | Zhao and Davies
Bcl-2+ cells from either of the other two cell populations 
(Fig. 7 B).
We next examined expression of Bcl-2 in cells expanded 
in  SCID  mice.  Mice  were  injected  with  purified  CD4+ 
CD44v.low cells or CD4+ CD44int cells, and the expression 
of Bcl-2 in the reconstituted CD4+ T cell subsets was deter-
mined. A significantly greater percentage of CD4+ CD44v.low 
cells  expressed  Bcl-2  than  CD4+  CD44int  and  CD4+  
CD44high  cells,  whether  they  were  derived  from  CD4+ 
CD44v.low, CD4+ CD44int cells, or from cells isolated from 
untreated BALB/c mice (Fig. 7 C). In addition, the per-
centage of CD4+ CD44high cells that expressed Bcl-2 was 
significantly greater when derived from CD4+ CD44v.low 
cells than when derived from CD4+ CD44int cells (Fig. 7 D), 
which  is  consistent  with  the  development  of  long-term 
memory cells.
A greater percentage of CD4+ CD44v.low cells expressed 
the IL-7 receptor CD127 than CD4+ CD44int cells in un-
treated control BALB/c mice (Fig. 7 E). After reconstitution 
of mice, CD127 was expressed on a significantly smaller per-
centage  of  total  CD4+ T  cells  when  derived  from  CD4+ 
CD44v.low cells, compared with total CD4+ T cells from mice 
infused with CD4+ CD44int cells (Fig. 7 F). However, the ab-
solute number of CD4+ T cells expressing CD127 was signifi-
cantly greater in recipients of CD4+ CD44v.low cells than in 
mice that received CD4+ CD44int cells (Fig. 7 G).
days 2 and 3. The percentage of the original cultured cells 
(precursor frequency) that had divided in response to anti-
CD3 and anti-CD28 in both groups was 18.0 ± 1.0% and 
33.5 ± 1.2% for the CD4+ CD44v.low cells and 14.9 ± 0.1% 
and 26.1 ± 1.1% for the CD4+ CD44int cells on days 2 and 3, 
respectively. The large percentage of divided cells seen in 
both CD4+ CD44v.low (Fig. 6 G) and CD4+ CD44int (Fig. 6 H) 
cultures reflects multiple rounds of division from individual 
precursor cells and was 39.7 ± 1.3% and 78.0 ± 1.3 for the 
CD4+ CD44v.low cells and 37.8 ± 0.6% and 73.6 ± 1.0% for 
the CD4+ CD44int cells on days 2 and 3, respectively. There-
fore, proliferation seen on day 3 of CD4+ CD44v.low cell cul-
tures represents variable rounds of division by one third of the 
original cultured cell population.
CD4+ CD44v.low cells show enhanced expression  
of the survival factors B cell leukemia/lymphoma 2 (Bcl-2) 
and CD127
Expression of high levels of the antiapoptotic factor Bcl-2 
(Mueller et al., 1996) and the IL-7 receptor CD127 (Sudo   
et  al.,  1993)  is  associated  with  prolonged T  cell  survival.   
In  splenocytes  from  untreated  mice,  a  significantly  higher 
percentage  of  CD4+  CD44v.low  cells  expressed  Bcl-2  than   
either CD4+ CD44int cells or CD4+ CD44high cells (Fig. 7 A). 
Moreover, the density of expression of Bcl-2 in Bcl-2+ cells 
was  significantly  greater  in  CD4+  CD44v.low  cells  than  in   
Figure 7.  CD4+ CD44v.low cells show enhanced expression of survival factors Bcl-2 and CD127. Splenocytes from untreated BALB/c mice (n = 4), 
CB17.SCID mice reconstituted 3 wk earlier with sorted CD4+ CD44v.low cells (n = 6), or an equal number of CD4+ CD44int cells (n = 6), were co-stained with 
mAbs specific for CD4, CD44, and Bcl-2 (A–D) or CD127 (E–G). (A and B) The percentage of Bcl-2+ CD4+ T cell subsets (A) and the mean fluorescence in-
tensity of Bcl-2 in Bcl-2+ cells (B) in untreated BALB/c mice are shown. (C) The percentage of Bcl-2+ cells in the indicated subsets in mice reconstituted 
with CD4+ CD44v.low cells (black bars), CD4+ CD44int cells (hatched bars), or in untreated BALB/c mice (white bars). (D) The percentage of Bcl-2+ CD44high 
CD4+ memory cells in mice reconstituted with CD4+ CD44v.low cells (black bar), CD4+ CD44int cells (hatched bar), or in untreated BALB/c mice (white bar).  
(E and F) The percentage of CD127+ CD4+ CD44v.low cells and CD4+ CD44int cells in untreated BALB/c splenocytes (E), and the percentage (F) and total num-
ber (G) of CD127+ CD4+ T cells in mice reconstituted with CD4+ CD44v.low cells (black bars) or CD4+ CD44int cells (hatched bars) is shown. Data are shown 
as mean ± SD, and are representative of two independent experiments. One-way ANOVA showed significance of P < 0001 for A, B, and D; P < 0.001, P = 
0.0085, and P < 0.0001 for CD4+ CD44v.low, CD4+ CD44int, and untreated BALB/c groups, respectively. P = 0.0013 for panel C. Significance between groups 
using Bonferroni’s multiple comparison test is indicated on the figures. *, P = 0.01–0.05; **, P = 0.001–0.01; ***, P < 0.001.JEM VOL. 207, December 20, 2010 
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the value given to that peak and the value given to the corre-
sponding peak for a control cell subset that shows a Gaussian 
distributed CDR3 spectratype (no clonal expansion). Experi-
mental peaks with an area greater than control peaks will have 
positive values (positive perturbation). The sum of all positive 
perturbation (total positive perturbation) for all peaks within 
a CDR3 spectratype is the perturbation for that TCR V 
CDR3 spectratype. The mean CDR3 spectratype perturba-
tion for all TCR V tested gives the overall sample perturba-
tion shown in Fig. 9. Significant perturbation in the spectratype 
reflects clonal expansion within that V family.
We hypothesized that cells derived from CD4+ CD44v.low 
cells might possess a greater TCR repertoire than cells de-
rived from other naive and memory cells.  To test this, we ex-
amined CDR3 spectratypes from the initial cells transferred, 
as well as from the in vivo–expanded populations. The CDR3 
spectratypes for TCR V1, 2, 4, 6, 7, 8.1, 8.2, 8.3, 10, 14, and 
15 for CD4+ T cells sorted from untreated BALB/c mice 
were determined and used as standard control spectratypes 
showing Gaussian distribution. We initially examined CDR3 
spectratypes for each V family in CD4+ CD44v.low, CD4+ 
CD44int,  and  CD4+  CD44high  cells  sorted  from  untreated 
BALB/c mice. The overall sample perturbation was shown to 
be between 4 and 6% for all CD4+ cell subsets tested (Fig. 9 A), 
demonstrating that the diversity of the TCR repertoire, as 
measured by this assay, is similar in the three CD4+ T cell 
populations isolated from untreated mice. This is also shown 
by the near Gaussian distribution of the CDR3 spectratypes 
in total CD4+, CD4+ CD44v.low, CD4+ CD44int, and CD4+ 
CD44high cells (Fig. 9 B).
To test the hypothesis that the diversity of the T cell rep-
ertoire derived from CD4+ CD44v.low cells is greater than that 
derived from CD4+ CD44int cells, CD4+ T cells were purified 
from SCID mice that had been infused with either CD4+ 
CD44v.low cells, or with CD4+ CD44int cells. CD4+ T cells 
isolated from mice infused with CD4+ CD44high cells were 
also included as a positive control because memory cells show 
evidence of clonal expansion after lymphopenia-induced 
proliferation (Eyrich et al., 2002). The data in Fig. 9 C show 
significant spectratype perturbation in CD4+ T cells purified 
from all three groups of SCID recipients, reflecting evidence 
of  clonal  expansion.  However,  the  overall  perturbation  of 
CD4+ T cells derived from CD4+ CD44v.low cells (17 ± 8%) is 
significantly less than that for either CD4+ CD44int (25 ± 
10%) or CD4+ CD44high (32 ± 16%) cells (Fig. 9 C). Fig. 9 D 
shows a representative CDR3 spectratype for TCR V10 in 
total  CD4+ T  cells,  CD4+  CD44v.low,  CD4+  CD44int,  and 
CD4+ CD44high cells. Although the CD4+ CD44v.low cells 
show a partial Gaussian distribution of the CDR3 products 
with different lengths, CD4+ CD44int and CD4+ CD44high 
cells do not. These data indicate a greater diversity in the 
TCR repertoire derived from CD4+ CD44v.low cells com-
pared with either CD4+ CD44int and CD4+ CD44high cells.
The ability to reconstitute a CD4+ T cell pool with a di-
verse TCR repertoire would predict proliferation of a large 
proportion of the CD4+ CD44v.low cells on transfer into 
CD4+ CD44v.low cells express a higher density of CD5  
than CD4+ CD44int cells
Cell surface expression of CD5 is proportional to the TCR 
signaling capacity of that cell in response to self-peptide/
MHC (Azzam et al., 1998), whereas a high surface density of 
TCR (Kassiotis et al., 2003) and CD4 (Strong et al., 2001) 
can increase T cell avidity for APC. The density of CD5 ex-
pression on CD4+ CD44v.low cells was significantly higher 
than that on CD4+ CD44int cells (Fig. 8 A), whereas expres-
sion of TCR (Fig. 8 B), CD4 (Fig. 8 C), and CD3 (Fig. 8 D) 
were similar between the two cell subsets.
T cell receptor repertoire diversity is significantly greater  
in CD4+ T cells derived from CD4+ CD44v.low cells than  
in cells derived from CD4+ CD44int cells
The complementary determining region 3 (CDR3) of the 
TCR confers antigen specificity (Jorgensen et al., 1992), and can 
vary in size depending on the number of nucleotides removed   
or added during rearrangement of TCR genes (Pannetier, 1993; 
Pannetier et al., 1995). The probability of distribution of vari-
ous CDR3 sizes provides a CDR3 spectratype, or pattern of 
peaks, which is Gaussian in the absence of clonal expansion 
(i.e.  maximum  diversity;  Pannetier,  1993).  Perturbation  of 
CDR3 spectratypes away from Gaussian can then be used as 
an indication of TCR repertoire diversity; the lower the per-
turbation, the greater the diversity. The peaks in a CDR3 
spectratype are given numerical values by determining the 
contribution of each peak to the total area under all peaks 
measured, where the sum of all peaks measured is 100%. The 
percentage of perturbation of a peak generated from an ex-
perimental cell subset is calculated as the difference between 
Figure 8.  CD4+ CD44v.low cells express a higher density of CD5 
than CD4+ CD44int cells. Splenocytes isolated from untreated BALB/c 
mice (n = 3) were co-stained with mAbs specific for CD4 and CD44 and 
CD5 (A), TCR (B), CD4 (C), or CD3 (D). The mean fluorescence intensity 
(MFI) of CD5, TCR, CD4, and CD3 on CD4+ CD44v.low and CD4+ CD44int cells 
was determined by FACS. Data are shown as mean ± SD and are represen-
tative of four independent experiments for CD5 and three independent 
experiments for TCR, CD4, and CD3. The two-tailed unpaired Student’s  
t test showed a significantly greater CD5 MFI on CD4+ CD44v.low cells than 
on CD4+ CD44int cells (P = 0.01–0.05)2890 Peripheral precursor of CD4+ T cell populations | Zhao and Davies
differentiates  into  naive,  memory,  and  Foxp3+  regulatory 
CD4+ T cell subsets having a diverse TCR repertoire. More-
over, their ability to reconstitute the CD4+ T cell pool is in-
dependent of cachexia, indicating the potential importance in 
enhancing  CD4+  CD44v.low  cell  numbers  and  function  to 
treat drug- and disease-induced lymphopenia.
Using  a  cell  transfer  model  in  which  highly  purified 
CD4+ T  cell  subsets  were  infused  into  immunodeficient 
SCID mice, we have found that CD4+ CD44v.low cells more 
efficiently generate large numbers of CD4+ T cells in immuno-
deficient recipients than other naive or memory CD4+ cells. 
Moreover, the ratio between naive and memory cells in mice 
reconstituted by CD4+ CD44v.low cells is the same as that   
seen in untreated wild-type mice, suggesting that the repopu-
lated cells are under homeostatic equilibrium. In addition,   
we showed that a significantly greater percentage of mem-
ory cells derived from CD4+ CD44v.low cells express Bcl-2 
than memory cells derived from CD4+ CD44int cells, suggest-
ing they may exhibit the survival characteristics of long-lived 
memory cells. Long-lived memory cells are derived from naive 
cells that experience strong antigen stimulation during the 
primary response to exogenous antigen (Williams et al., 2008), 
and this is consistent with our finding that CD4+ CD44v.low 
cells express a high density of CD5, which is a characteristic 
of cells with high TCR signaling capacity for self-peptide/
MHC (Azzam et al., 1998). CD4+ CD44v.low cells also express 
high levels of Bcl-2 (Mueller et al., 1996), as well as CD127, 
the IL-7 receptor (Sudo et al., 1993), which is consistent with 
CB17.SCID  mouse  recipients. To  test  this,  sorted  CD4+ 
CD44v.low cells and CD4+ CD44int cells were labeled with 
CFSE and infused into CB17.SCID mouse recipients as be-
fore. By day 8 after infusion, the majority of CD4+ cells from 
spleens of mice infused with CD4+ CD44v.low cells had di-
vided between 3 and 6 times (Fig. 9 E). In general, prolifera-
tion of the CD4+ CD44int population was more extensive at 
this time point, with the majority of infused cells dividing 
more than 6 times in most of the recipient mice (Fig. 9 F). By 
days 14 and 21 after cell infusion, over 90% of the infused cells 
in all of the mice in both groups had divided >7 times (Fig. 9,   
E and F) suggesting that the majority of the CD44v.low popula-
tion contribute to the reconstitution of CD4+ T cells in SCID 
mouse recipients.
DISCUSSION
The functional importance of the CD4+ CD44v.low cell popu-
lation was suggested by their ability to significantly delay the 
onset of cachexia and lymphopenia in mice with a profound 
tumor burden (Wang et al., 2008). Although lymphopenia can 
also be overcome by proliferation and differentiation of naive 
and memory cells (Freitas and Rocha, 2000; Jameson, 2002; 
Wu et al., 2004), neither CD4+ CD44int naive cells nor mem-
ory CD4+ T cells inhibit cachexia-associated lymphopenia, 
suggesting that the CD4+ CD44v.low cell subset might be the 
dominant peripheral CD4+ T cell precursor population in   
a cachexic environment. Here, we extend these findings   
to show that the CD4+ CD44v.low cell subset expands and   
Figure 9.  T cell receptor repertoire diversity is 
significantly greater in CD4+ T cells derived from 
CD4+ CD44v.low cells than in cells derived from 
CD4+ CD44int cells. CD4+ CD44v.low (n = 2), CD4+ 
CD44int (n = 2), and CD4+ CD44high (n = 2) cells were 
sorted from BALB/c splenocytes, and an equal num-
ber of each subset (106) was used to determine the 
TCR V perturbation of the CDR3 spectratype.  
(A) The overall sample perturbation (% perturbation) 
includes the perturbation of TCR V1, 2, 4, 6, 7, 8.1, 
8.2, 8.3, 10, 14, and 15 for each cell subset. The CDR3 
spectratype profile for each subset is shown for 
V10 (B). In a separate experiment, CD4+ cells from 
individual mice were either enriched or sorted from 
CB17.SCID mice that were injected 3 wk earlier with 
2.5 × 105 sorted CD4+ CD44v.low (n = 5), CD4+ CD44int 
(n = 5), or CD4+ CD44high (n = 5) cells. Either 5 × 105 
enriched cells or 2.4–3.0 × 105 sorted cells were used 
for CDR3 spectratype analysis. (C) The total pertur-
bation for each of the TCR V tested in each CD4+  
T cell subset was determined. In A and C, the dots 
represent the perturbation for each TCR V tested in 
each individual mouse, and the horizontal line represents the mean of all TCR V tested for all mice in each group. The CDR3 spectratype profile for TCR 
V10 is shown for total CD4+ T cells and all CD4+ T cell subsets tested (D). The experiment was performed three times, and the data shown are pooled 
from all three independent experiments. (E and F) 2.5 × 105 sorted CFSE-labeled CD4+ CD44v.low cells (n = 9) or CD4+ CD44int cells (n = 9) were infused into 
CB17.SCID recipients. CFSE intensity in CD4+ splenocytes was determined on days 8 (n = 3), 14 (n = 3), and 21 (n = 3) after cell infusion. Histograms show 
representative examples of the CFSE intensity in CD4+ splenocytes from CD4+ CD44v.low-infused (E) or CD4+ CD44int-infused (F) mice at each time point. 
The data are representative of two independent experiments. One-way ANOVA showed significance of P < 0001 for C. Significance between groups using 
Bonferroni’s multiple comparison test is indicated on the figures. **, P = 0.001–0.01; ***, P < 0.001.JEM VOL. 207, December 20, 2010 
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The  absence  of  Foxp3+  regulatory  cells  in  the  CD4+ 
CD44v.low cell population that reconstituted CD4+ cells when 
transferred in lymphopenic hosts, might suggest the potential 
for  autoimmunity  in  the  expanded  population  (Haribhai   
et al., 2009). However, we found no evidence of autoimmu-
nity in SCID mice injected with purified CD4+ CD44v.low 
cells (our unpublished data). It is possible that conversion of 
CD4+ CD44v.low Foxp3 cells to aTregs prevents the develop-
ment of autoimmunity. Alternatively, because CD5 is known 
to be a negative regulator for TCR signaling (Brossard et al., 
2003), and plays a role in protection from activation-induced 
cell death (Friedlein et al., 2007), its higher expression on 
CD4+ CD44v.low cells might allow efficient accumulation of 
these cells in vivo while suppressing the potential for autoim-
munity. Such a possibility has been described for other cell 
populations that express a high density of CD5 (Kassiotis   
et al., 2003; Dalloul, 2009).
In addition to recognition of self-peptide/MHC (Viret   
et al., 1999; Moses et al., 2003), lymphopenia-induced prolif-
eration  of  naive  cells  requires  the  survival  cytokine,  IL-7 
(Maraskovsky et al., 1996; Tan et al., 2001). Signaling in re-
sponse to IL-7 results in down-regulation of its own receptor, 
CD127, thus limiting the expansion of IL-7–stimulated clones 
without limiting the expansion of the cell population as a 
whole, and maintaining TCR diversity (Park et al., 2004). 
Our data show that after expansion in vivo, the percentage of 
CD4+ T cells that express CD127 is reduced to a significantly 
greater extent on CD4+ T cells derived from CD4+ CD44v.low 
than it is on cells derived from CD4+ CD44int cells, predicting 
less clonal expansion and greater TCR diversity in the former. 
Indeed,  we  found  that  the TCR  repertoire  generated  by 
CD4+ CD44v.low cells is significantly greater than that gener-
ated by CD4+ CD44int cells. The finding that the majority of 
the CD4+ CD44v.low cells divide in SCID mice in vivo is 
consistent with the notion that a large proportion of the in-
fused cells contribute to the reconstitution and diversity of 
the TCR repertoire. The diversity of the CD4+ TCR reper-
toire derived form naive CD4+ CD44int cells is significantly 
greater than that seen for CD4+ T cells derived from memory 
CD4+ T cells, and this is consistent with published data that 
compares the TCR diversity in CD4+ T cells derived from 
naive and memory cells (Eyrich et al., 2002).
Proliferation of CD4+ CD44v.low cells in response to anti-
CD3  stimulation  in  vitro  is  dependent  on  co-stimulation, 
identifying them functionally as naive CD4+ T cells (Croft 
and Dubey, 1997). Furthermore, they are more dependent on 
co-stimulation than CD4+ CD44int naive cells, and secrete 
significantly less IL-2 than their CD4+ CD44int naive cell 
counterparts. These observations suggest that CD4+ CD44v.low 
cells may represent the most naive population within the total 
naive cell subset. Importantly, CD4+ CD44v.low cells are not 
recent  thymic  emigrants  because  they  do  not  express  the 
characteristic patterns of CD3, CD127, CD28, CD45RB, and 
CD31 (unpublished data) that have been used to define re-
cent thymic emigrants ( Jores and Meo, 1993; Kimmig et al., 
2002; Boursalian et al., 2004).
a survival advantage for CD4+ CD44v.low cells leading to effi-
cient accumulation in vivo.
The ability of CD4+ CD44v.low cells to generate a naive 
CD4+ T cell pool in profoundly lymphopenic hosts chal-
lenges the current paradigm that the naive cell compartment 
can only be reconstituted by thymopoiesis (Ge et al., 2002). 
This paradigm was originally based on the finding that al-
though naive cells rapidly differentiate into memory pheno-
type cells when infused into irradiated hosts (Ernst et al., 
1999: Goldrath and Bevan, 1999), they were unable to recon-
stitute the naive cell compartment (Greenberg and Riddell, 
1999). A later study countered that by suggesting that naive   
T cells could reconstitute irradiated mice with cells of both 
naive and memory phenotype, and that the naive cells were 
derived  from  cells  that  transiently  expressed  the  memory 
phenotype (Goldrath et al., 2000). Finally, Ge et al. (2002) 
have shown that the previous findings might be explained by 
lymphoid stem cells present in the cell injection, and that   
naive cell reconstitution could not be achieved with purified 
naive T cells alone. In their study, Chen et al. further showed 
that naive cell reconstitution was thymus dependent, which 
confirmed the prevailing paradigm that the naive cell com-
partment can only be reconstituted by thymopoiesis. Our 
data challenge this paradigm by identifying a novel peripheral 
CD4 T cell subset (CD44v.low cells) that can reconstitute the 
naive cell compartment in thymectomized SCID mice.
The Foxp3+ regulatory cell subset Tregs (Fontenot and 
Rudensky, 2005; Mucida et al., 2005) play a role in main-
taining a healthy immune system by limiting undesirable 
immune responses. Tregs can be divided into two major sub-
sets on the basis of their development, natural and acquired, 
and  constitute  5–10%  of  total  CD4+ T  cells  in  healthy 
BALB/c mice. Natural Tregs (nTregs) are thought to be a 
separate, thymus-derived lineage of T cells (Fontenot et al., 
2003; Khattri et al., 2003), whereas aquired Tregs (aTregs) 
can be generated from naive CD4+ Foxp3 T cells in the 
periphery (Apostolou and von Boehmer, 2004; Kretschmer 
et al., 2005). Tregs are undetectable within the CD4+ CD44v.low 
cell population, but are readily detectable within the CD4+ 
CD44int and CD4+ CD44high cells. CD4+ CD44int cells that 
are experimentally depleted of Foxp3+ cells are inefficient 
in generating a Foxp3+ population during lymphopenia-
induced proliferation. In sharp contrast, CD4+ CD44v.low 
cells readily differentiate to express Foxp3 during homeo-
static reconstitution, with >10% of CD4+ CD44v.low-derived 
cells expressing Foxp3 by 3 wk after transfer into SCID re-
cipients. Approximately 2–6 × 105 CD4+ Foxp3+ cells are 
generated from the original 2.5 × 105 CD4+ CD44v.low 
cells transferred. Because it is unlikely that this large number 
of Foxp3+ cells was derived from proliferation of a small   
undetectable  Foxp3+  population  present  in  the  original 
CD4+ CD44v.low cell infusion, the data strongly suggest con-
version of CD4+ CD44v.low Foxp3 cells to aTregs. Regard-
less of the exact mechanism, our data suggest that CD4+ 
CD44v.low cells are the main precursor population for the 
generation of Tregs.2892 Peripheral precursor of CD4+ T cell populations | Zhao and Davies
Cultures were stimulated with plate-bound anti-CD3 (145-2C11) and anti-
CD28 (37.51) mAb (BD) at 1 µg/ml for 2, 3, 4, and 5 d (a different plate for 
each time point) in RPMI culture medium (Invitrogen) with 5% fetal bovine 
serum  (InterGen),  Hepes  (Invitrogen),  glutamine,  penicillin,  streptomycin 
(Irvine Scientific), and 2-mercaptoethanol (Sigma-Aldrich). To measure pro-
liferation, cells were pulsed with [3H]thymidine (0.5 µCi/well; GE Health-
care), and harvested 16 h later. Incorporation of [3H]thymidine was measured 
on a scintillation -counter (Wallac; PerkinElmer). In other experiments, 
sorted cells were labeled with CFSE (Invitrogen) using the standard published 
protocol (Lyons and Parish, 1994) before culture, and their proliferation was 
measured by CFSE dilution. Precursor frequency was calculated using FlowJo 
version 8.8.6 (Tree Star, Inc.). IL-2 content in cultured cells was determined 
by intracellular stain and FACS, and in the culture supernatant by ELISA.
Analysis of TCR repertoire modifications by CDR3 spectratyping. 
Random rearrangement of TCR variable (V), diversity (D), joining (J), and 
constant (C) region results in enormous diversity in the TCR repertoire 
(Pannetier, 1993; Jores and Meo, 1993). In this study, the CDR3 spectratype 
for V-C combinations in eleven different TCR V families (BV-BC reper-
toire) was used to compare the diversity of the TCR repertoire in different 
CD4+ T cell subsets. The perturbation of the BV-BC repertoire for each V 
family  in  CD4+ T  cell  populations  after  homeostatic  and  lymphopenia- 
induced proliferation was compared with unstimulated CD4+ T cells (Gorochov 
et al., 1998; Han et al., 1999). The mean BV-BC perturbation for all TCR  V 
tested is calculated to give the overall sample perturbation tested, and this is 
compared between cell subsets.
Typically, the CDR3 spectratype from unstimulated CD4+ T cells con-
sists of six or seven discrete and easily identifiable peaks (Fig. 9, B and D, for 
CD4+ cells). The area under each peak for a given TCR V is determined 
using GeneMapper Software, and the contribution of each peak to the total 
area under all peaks for that TCR V family is calculated as a percentage.  This   
is shown for V10 in Table S2. The CDR3 spectratype is constant in unstim-
ulated CD4+ T cells isolated from different BALB/c mice (Table S3), and is 
also unaffected by differences in the cell number used for RNA isolation if 
between 105 and 106 (Table S4). The CDR3 spectratype for each experimen-
tal cell subset was compared with that of the unstimulated control cells (Table S5). 
The perturbation for each TCR V peak is the difference between the per-
cent value given to the control peak and the percent value given to the cor-
responding experimental peak. Experimental peaks with an area greater, and 
lower, than control peaks will have positive values (positive perturbation) and 
negative (negative perturbation) values, respectively. The sum all positive per-
turbation (total positive perturbation) for each TCR V family is calculated, 
and the mean for all TCR V tested gives the overall sample perturbation 
shown in Fig. 9. It is important to note that the total positive perturbation is 
equal to the total negative perturbation.
Protocol used to generate product for CDR3 spectratyping. Total 
RNA was extracted from highly purified CD4+ T cell subsets using the 
RNeasy  Mini  kit  (QIAGEN).  cDNA  was  synthesized  using  oligo  (dT)   
12–18 superscript reverse transcription (Invitrogen) at 42°C for 50 min (min) 
followed by 15 min at 70°C. PCR amplification of newly synthesized cDNA 
was performed in a mixture containing 0.75 U of AmpliTaq DNA Poly-
merase (Applied Biosystems), 1.5 mM MgCl2, 0.25 mM dNTP, and 0.5 µM 
C145 primer with V1, 2, 4, 6, 7, 8.1, 8.2, 8.3, 10, 14, and 15 primers 
(primer sequences are listed in Table S6) for 2 min at 94°C, followed by 39 
cycles of 45 s at 94°C, 45 s at 60°C, 45 s at 72°C, and finally 10 min at 72°C. 
Run-off reactions were performed with 0.04 µM of a C5-specific FAM- 
labeled primer in a mixture of Taq DNA polymerase (New England Bio-
Labs), 3 mM MgCl2, and 0.2 mM dNTP for 11 s at 94°C, followed by 15 
cycles of 45 s at 94°C, 45 s at 55°C, 1 min at 72°C, and finally 5 min at 72°C. 
All PCR reactions were performed on a 96-well GeneAmp PCR System 
9700 (Applied Biosystems). Run-off products were denatured in deionized 
formamide with a GeneScan HD (ROX; Applied Biosystems) size standard 
(Applied Biosystems). The mixture was incubated for 2 min at 94°C and 
cooled on ice for 5 min. Fragment analysis of the denatured products was 
In summary, this study further describes the properties of a 
new CD4+ T cell subset, the CD4+ CD44v.low cells. This cell 
subset has all of the phenotypic and functional characteristics of 
naive CD4+ T cells. Its unique ability to repopulate naive, mem-
ory, and Foxp3+ regulatory CD4+ T cell subsets with a diverse 
TCR repertoire, independent of the thymus, indicate its role as 
a peripheral precursor responsible for maintaining immune in-
tegrity. Strategies that promote CD4+ CD44v.low cell numbers 
and/or function might therefore be critical for the treatment of 
lymphopenia and lymphopenia-associated disease.
MATERIALS AND METHODS
Mice. Euthymic and thymectomized CBySmn.CB17-Prkdcscid/J mice (CB17.
SCID) and BALB/cByJ (BALB/c) mice were purchased from The Jackson 
Laboratory. As a standard precaution, at the end of each experiment involving 
thymectomized mice, fibrous and fatty tissue remaining at the site of surgery 
was removed and analyzed by FACS for the presence CD3+ cells to confirm 
complete thymectomy. Foxp3EGFP mice (Foxp3-GFP) on the BALB/c back-
ground were a gift from T. Chatila (University of California, Los Angeles, Los 
Angeles, CA), and bred at the Torrey Pines Institute for Molecular Studies. 
Mice were maintained under specific pathogen–free conditions and used be-
tween 8–20 wk of age. All experiments were approved by the Torrey Pines In-
stitute for Molecular Studies Institutional Animal Care and Use Committee.
Phenotypic analysis by FACS. mAbs specific for CD4 (RM4-5 conju-
gated to either allophycocyanin [APC] or PE-Cy7), CD8 (53–6.7 conju-
gated to APC), CD44 (IM7 conjugated to either PE or APC), CD5 (53–7.3 
conjugated to FITC), TCR (H57597 conjugated to APC), CD3 (145-
2C11, conjugated to either FITC or PE), CD45RB (16A conjugated to PE), 
CD25  (PC61  conjugated  to  PE-Cy7),  CD28  (37.51  conjugated  to  PE), 
CD31 (MEC13.3 conjugated to FITC), and IL-2 (JES6-5H4 conjugated to 
PE) were purchased from BD. mAbs specific for Foxp3 (FJK-16s conjugated 
to FITC) and CD127 (A7R34 conjugated to PE-Cy7) were purchased from 
eBioscience. Bcl-2 expression was determined using the FITC Anti–Mouse 
Bcl-2 Set following manufacturer’s instructions (BD). All experiments in-
cluded relevant isotype controls. Cells were acquired on a FACSCalibur and 
analyzed using either CellQuest version 3.3 (BD) or FlowJo version 8.8.6 
(Tree Star, Inc.).
Cell subset purification. CD4+ cells were enriched from splenocytes by 
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with the lowest CD44 density, the CD4+ CD44int cells were the 30% of CD4+ 
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Adoptive transfer. Sorted cells were washed once in PBS, and between   
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their proliferation was measured by CFSE dilution.
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Statistical analysis. Statistical analysis to compare CD4+ cell subset recon-
stitution, expression of Bcl-2, and percentage of perturbation of the CDR3 
spectratype, was performed using one-way analysis of variance (ANOVA), 
followed by the Bonferroni multiple comparison test. Comparisons between 
reconstitution by two cell subsets in thymectomized and euthymic mice, and 
by intravenous and peritoneal injection, were performed using the Student’s 
t test. Comparison of CD5, TCR, CD4, CD3, and CD127 expression and 
cell division based on CFSE dilution was performed using the unpaired Stu-
dent’s t test. Comparison of proliferation, IL-2 production, and IL-2 secretion 
was performed using two-way ANOVA, followed by the Bonferroni multiple 
comparison test. A p-value <0.05 is considered significant. Significance is de-
termined using the data presented in each figure.
Online supplemental material. Fig. S1 shows the percentage of CD4+ 
CD44v.low,  CD4+  CD44int,  and  CD4+  CD44high  cells  that  express  Foxp3.   
Fig. S2 shows CD44 expression on CD4+ CD44v.low, CD4+ CD44int, and 
CD4+ CD44high cells before and after sorting. Table S1 shows that CD4+ 
Foxp3+ cells can be found in the CD4+ CD44int and CD4+ CD44high subsets, 
but not in the CD4+ CD44v.low subset. Table S2 shows how the percentage 
contribution of each spectratype peak within a V family is calculated, using 
VB10 as an example. Table S3 shows that the contribution of each spectra-
type peak within a  V family is consistent in CD4+ T cells isolated from three 
individual untreated BALB/c mice, using  V10 as an example. Table S4 shows 
that the distribution of CDR3 regions with different lengths within a V 
family does not change if the number of CD4+ T cells analyzed at one time 
is between 105 and 106. Table S5 shows the strategy used to calculate the total 
perturbation of each TCR V family using V 10 as an example. Table S6   
shows the sequence of mouse V and C primers used for immunoscope 
analysis. Online supplemental material is available at http://www.jem.org/ 
cgi/content/full/jem.20100598/DC1.
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